NCT07578974 Foot-Core Training With/Without Visual Feedback in Pediatric FPP
| NCT ID | NCT07578974 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Flexible Flatfoot |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2026-04-13 |
| Primary Completion | 2026-07-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2026-04-13 with a primary completion date of 2026-07-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates flexible pes planus (flat feet) in children, a condition where the medial arch collapses during weight-bearing, affecting gait, balance, and foot function. Although foot-core strengthening and visual feedback individually improve arch stability and motor control, their combined effect in pediatric populations remains underexplored. To address this gap, a randomized controlled trial will be conducted at Rafia Grammar School, involving 24 children aged 7-12 years with clinically confirmed flexible pes planus. Participants will be randomly assigned into two groups: one receiving foot-core training alone and the other receiving foot-core training with visual feedback, with interventions carried out twice weekly for 8 weeks. Changes in foot posture and gait will be assessed using standardized outcome measures, and data will be analyzed using SPSS version 23.0. The study aims to determine whether adding visual feedback enhances treatment effectiveness and supports the development of more targeted, evidence-based pediatric rehabilitation strategies.
Eligibility Criteria
Inclusion Criteria: * Children aged 7-12 years with confirmed flat feet * Both Genders * Flexibility of flatfeet; tested using Tip toe standing test and Jack's test. * Navicular Drop (\>10mm) * Mini Mental State Examination score \> 21 * Visual acuity of 20/40 (6/12) or better in both eyes, confirmed by Snellen chart test. * Foot Posture Index-6 (FPI-6, \> +6) * Children demonstrate altered gait parameters consistent with flexible pes planus as measured by temporal-distance gait analysis. * Arch Height Index (\< 0.31) * Medial Longitudinal Arch Angle (\<130°) * Calcaneal Eversion Angle ( \>5° eversion) * Subtalar ROM (Dorsiflexion \<10°) * Footprint Index (Staheli \>1.0 or Chippaux \>45%) * Dynamic Balance; Y-Balance Test (\<85% composite score) * Functional Scale (LEFS) (\<60%) Exclusion Criteria: * Children with tarsal coalitions * Congenital defects of lower limbs * Previous foot surgery * Foot/ankle trauma within the last six (6) months * Received balance training or feet muscle strengthening within the last 3 months * Visual and vestibular disturbance * A history of head injury within the last 3 months * Weakness of lower extremities (Manual Muscle testing grade \<5)
Contact & Investigator
Hafiza Syeda Javeria Fayyaz, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07578974 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 12 Years, studying Flexible Flatfoot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07578974 currently recruiting?
Yes, NCT07578974 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07578974 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07578974 clinical trial?
NCT07578974 is sponsored by Riphah International University. The principal investigator is Hafiza Syeda Javeria Fayyaz, MS-PT at Riphah International University. The trial plans to enroll 24 participants.